Search all trials

Find therapies in clinical trials near you – page 38

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 955
countries: 28
conditions: 2 101

3 955 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Omalizumab

Contact Research Centre

Chronic graft versus host disease

Not recruiting

Registered drug

Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Study on Luspatercept for Patients with Lower-risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Not recruiting

Registered drugNo placebo

Study on Luspatercept for Patients with Lower-risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Pembrolizumab and Drug Combination for Patients with Stage III Melanoma Eligible for Neoadjuvant Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Breast cancer+3

Not recruiting

Registered drug

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Pembrolizumab and Tretinoin in Patients with PD-1 Refractory Melanoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Investigational

Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

Investigational

France

Participants:18–64 years · 65+ years
Substances:Xevinapant

Contact Research Centre

Gastric cancer+7

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Hormone receptor positive breast cancer

Not recruiting

Registered drugNo placebo

Study of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer

Registered drugNo placebo

France

Participants:65+ years
Substances:Anastrozole

Contact Research Centre

Anal squamous cell carcinoma+4

Not recruiting

Registered drugNo placebo

Study of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 38

648 trials match your criteria

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Chronic spontaneous urticaria

Study on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

Chronic graft versus host disease

Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

Plasma cell myeloma

Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

Study on Luspatercept for Patients with Lower-risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Study on Luspatercept for Patients with Lower-risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Malignant melanoma

Study on the Safety and Effectiveness of Pembrolizumab and Drug Combination for Patients with Stage III Melanoma Eligible for Neoadjuvant Therapy

Breast cancer+3

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Malignant melanoma

Study on the Safety and Effectiveness of Pembrolizumab and Tretinoin in Patients with PD-1 Refractory Melanoma

Squamous cell carcinoma of head and neck

Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

Gastric cancer+7

Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

Hormone receptor positive breast cancer

Study of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer

Anal squamous cell carcinoma+4

Study of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.